269 related articles for article (PubMed ID: 32475748)
21. Primary graft dysfunction.
Criner RN; Clausen E; Cantu E
Curr Opin Organ Transplant; 2021 Jun; 26(3):321-327. PubMed ID: 33938469
[TBL] [Abstract][Full Text] [Related]
22. Reduction of primary graft dysfunction using cytokine adsorption during organ preservation and after lung transplantation.
Ghaidan H; Stenlo M; Niroomand A; Mittendorfer M; Hirdman G; Gvazava N; Edström D; Silva IAN; Broberg E; Hallgren O; Olm F; Wagner DE; Pierre L; Hyllén S; Lindstedt S
Nat Commun; 2022 Jul; 13(1):4173. PubMed ID: 35882835
[TBL] [Abstract][Full Text] [Related]
23. Clinical significance of donor lung weight at procurement and during ex vivo lung perfusion.
Okamoto T; Ayyat KS; Sakanoue I; Niikawa H; Said SA; Ahmad U; Unai S; Bribriesco A; Elgharably H; Budev MM; Yun JJ; McCurry KR
J Heart Lung Transplant; 2022 Jun; 41(6):818-828. PubMed ID: 35307267
[TBL] [Abstract][Full Text] [Related]
24. Soluble Adhesion Molecules During Ex Vivo Lung Perfusion Are Associated With Posttransplant Primary Graft Dysfunction.
Hashimoto K; Cypel M; Kim H; Machuca TN; Nakajima D; Chen M; Hsin MK; Zamel R; Azad S; Waddell TK; Liu M; Keshavjee S
Am J Transplant; 2017 May; 17(5):1396-1404. PubMed ID: 27977885
[TBL] [Abstract][Full Text] [Related]
25. The Conversional Efficacy of Ex Vivo Lung Perfusion and Clinical Outcomes in Patients Undergoing Transplantation of Donor Lungs by Ex Vivo Lung Perfusion: A Meta-Analysis.
Luo Q; Zhu L; Wang Y; Wang L; Lv W; Hu J
Ann Transplant; 2019 Dec; 24():647-660. PubMed ID: 31879416
[TBL] [Abstract][Full Text] [Related]
26. Limited cumulative experience with ex vivo lung perfusion is associated with inferior outcomes after lung transplantation.
Chen Q; Malas J; Krishnan A; Thomas J; Megna D; Egorova N; Chikwe J; Bowdish ME; Catarino P
J Thorac Cardiovasc Surg; 2024 Jan; 167(1):371-379.e8. PubMed ID: 37156369
[TBL] [Abstract][Full Text] [Related]
27. Lungs donated after circulatory death and prolonged warm ischemia are transplanted successfully after enhanced ex vivo lung perfusion using adenosine A2B receptor antagonism.
Charles EJ; Mehaffey JH; Sharma AK; Zhao Y; Stoler MH; Isbell JM; Lau CL; Tribble CG; Laubach VE; Kron IL
J Thorac Cardiovasc Surg; 2017 Nov; 154(5):1811-1820. PubMed ID: 28483262
[TBL] [Abstract][Full Text] [Related]
28. Donor Lung Preservation at 10°C: Clinical and Logistical Impact.
Gil Barturen M; Laporta Hernández R; Romero Berrocal A; Pérez Redondo M; Gómez Lozano N; Martín López J; Royuela Vicente A; Romero Román A; Hoyos Mejía L; Crowley Carrasco S; Gómez de Antonio D; Naranjo Gómez JM; Córdoba Peláez M; Novoa NM; Campo-Cañaveral de la Cruz JL
Arch Bronconeumol; 2024 Jun; 60(6):336-343. PubMed ID: 38644153
[TBL] [Abstract][Full Text] [Related]
29. Evaluating acellular versus cellular perfusate composition during prolonged ex vivo lung perfusion after initial cold ischaemia for 24 hours.
Becker S; Steinmeyer J; Avsar M; Höffler K; Salman J; Haverich A; Warnecke G; Ochs M; Schnapper A
Transpl Int; 2016 Jan; 29(1):88-97. PubMed ID: 26264867
[TBL] [Abstract][Full Text] [Related]
30. Technique for prolonged normothermic ex vivo lung perfusion.
Cypel M; Yeung JC; Hirayama S; Rubacha M; Fischer S; Anraku M; Sato M; Harwood S; Pierre A; Waddell TK; de Perrot M; Liu M; Keshavjee S
J Heart Lung Transplant; 2008 Dec; 27(12):1319-25. PubMed ID: 19059112
[TBL] [Abstract][Full Text] [Related]
31. Effects of immediate versus delayed ex-vivo lung perfusion in a porcine cardiac arrest donation model.
Olbertz C; Pizanis N; Bäumker H; Becker S; Aigner C; Rauen U; Nolte I; Kamler M; Koch A
Int J Artif Organs; 2019 Jul; 42(7):362-369. PubMed ID: 31238824
[TBL] [Abstract][Full Text] [Related]
32. Protein expression profiling predicts graft performance in clinical ex vivo lung perfusion.
Machuca TN; Cypel M; Yeung JC; Bonato R; Zamel R; Chen M; Azad S; Hsin MK; Saito T; Guan Z; Waddell TK; Liu M; Keshavjee S
Ann Surg; 2015 Mar; 261(3):591-7. PubMed ID: 25371129
[TBL] [Abstract][Full Text] [Related]
33. Effects of cold or warm ischemia and ex-vivo lung perfusion on the release of damage associated molecular patterns and inflammatory cytokines in experimental lung transplantation.
Hasenauer A; Bédat B; Parapanov R; Lugrin J; Debonneville A; Abdelnour-Berchtold E; Gonzalez M; Perentes JY; Piquilloud L; Szabo C; Krueger T; Liaudet L
J Heart Lung Transplant; 2021 Sep; 40(9):905-916. PubMed ID: 34193360
[TBL] [Abstract][Full Text] [Related]
34. Risk factors and survival impact of primary graft dysfunction after lung transplantation in a single institution.
Samano MN; Fernandes LM; Baranauskas JC; Correia AT; Afonso JE; Teixeira RH; Caramori ML; Pêgo-Fernandes PM; Jatene FB
Transplant Proc; 2012 Oct; 44(8):2462-8. PubMed ID: 23026621
[TBL] [Abstract][Full Text] [Related]
35. Beware Cold Agglutinins in Organ Donors! Ex Vivo Lung Perfusion From an Uncontrolled Donation After Circulatory-Determination-of-Death Donor With a Cold Agglutinin: A Case Report.
Venkataraman A; Blackwell JW; Funkhouser WK; Birchard KR; Beamer SE; Simmons WT; Randell SH; Egan TM
Transplant Proc; 2017 Sep; 49(7):1678-1681. PubMed ID: 28838463
[TBL] [Abstract][Full Text] [Related]
36. Normothermic ex-vivo preservation with the portable Organ Care System Lung device for bilateral lung transplantation (INSPIRE): a randomised, open-label, non-inferiority, phase 3 study.
Warnecke G; Van Raemdonck D; Smith MA; Massard G; Kukreja J; Rea F; Loor G; De Robertis F; Nagendran J; Dhital KK; Moradiellos Díez FJ; Knosalla C; Bermudez CA; Tsui S; McCurry K; Wang IW; Deuse T; Lesèche G; Thomas P; Tudorache I; Kühn C; Avsar M; Wiegmann B; Sommer W; Neyrinck A; Schiavon M; Calabrese F; Santelmo N; Olland A; Falcoz PE; Simon AR; Varela A; Madsen JC; Hertz M; Haverich A; Ardehali A
Lancet Respir Med; 2018 May; 6(5):357-367. PubMed ID: 29650408
[TBL] [Abstract][Full Text] [Related]
37. The impact and relevance of techniques and fluids on lung injury in machine perfusion of lungs.
Ponholzer F; Dumfarth J; Krapf C; Pircher A; Hautz T; Wolf D; Augustin F; Schneeberger S
Front Immunol; 2024; 15():1358153. PubMed ID: 38510260
[TBL] [Abstract][Full Text] [Related]
38. Ex Vivo Lung Perfusion Improves the Inflammatory Signaling Profile of the Porcine Donor Lung Following Transplantation.
Stone JP; Ball AL; Crichley W; Yonan N; Liao Q; Sjöberg T; Steen S; Fildes JE
Transplantation; 2020 Sep; 104(9):1899-1905. PubMed ID: 32502131
[TBL] [Abstract][Full Text] [Related]
39. Remote ex vivo lung perfusion at a centralized evaluation facility.
Mallea JM; Hartwig MG; Keller CA; Kon Z; Iii RNP; Erasmus DB; Roberts M; Patzlaff NE; Johnson D; Sanchez PG; D'Cunha J; Brown AW; Dilling DF; McCurry K
J Heart Lung Transplant; 2022 Dec; 41(12):1700-1711. PubMed ID: 36229329
[TBL] [Abstract][Full Text] [Related]
40. Outcomes of marginal donors for lung transplantation after ex vivo lung perfusion: A systematic review and meta-analysis.
Tian D; Wang Y; Shiiya H; Sun CB; Uemura Y; Sato M; Nakajima J
J Thorac Cardiovasc Surg; 2020 Feb; 159(2):720-730.e6. PubMed ID: 31548078
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
